Background pattern
LEXXEMA 1 mg/g CUTANEOUS EMULSION

LEXXEMA 1 mg/g CUTANEOUS EMULSION

Ask a doctor about a prescription for LEXXEMA 1 mg/g CUTANEOUS EMULSION

5.0(2)
Doctor

Tomasz Grzelewski

Dermatology21 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
CameraBook a video appointment
€80
Today11:00
Today11:25
Today11:50
Today12:15
Today12:40
More times
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use LEXXEMA 1 mg/g CUTANEOUS EMULSION

Introduction

Package Leaflet: Information for the User

Lexxema 1mg/g Cutaneous Emulsion

Methylprednisolone aceponate

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again. If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What Lexxema emulsion is and what it is used for
  2. What you need to know before starting to use Lexxema emulsion
  3. How to use Lexxema emulsion
  4. Possible side effects
  5. Storage of Lexxema emulsion
  6. Package contents and additional information

1. What Lexxema Emulsion is and What it is Used for

Lexxema emulsion contains the active substance methylprednisolone aceponate.

Lexxema emulsion is an anti-inflammatory medication (a corticosteroid) for use on the skin.

Lexxema reduces inflammation and allergic reactions of the skin, as well as reactions associated with excessive cell multiplication (hyperproliferation). Therefore, it reduces redness (erythema), fluid accumulation (edema), and exudate on inflamed skin. It also relieves itching, burning, or pain.

Lexxema emulsion is used in the treatment of acute forms of:

  • Rash (eczema) mild to moderate related to an external cause, such as:
    • Allergic reaction to a substance that has come into contact with the skin (allergic contact dermatitis).
    • Allergic reaction to substances of habitual use, such as soap (irritant contact dermatitis).
    • Nummular eczema.
    • Dyshidrotic eczema.
    • Unspecified eczema (vulgar eczema).
  • Eczema related to patient factors (endogenous eczema), such as atopic dermatitis or neurodermatitis.
  • Skin rash with inflammation and scaling (seborrheic eczema).

2. What You Need to Know Before Starting to Use Lexxema Emulsion

Do not use Lexxema emulsion

  • If you are allergic to the active ingredient methylprednisolone aceponate (MPA) or to any of the other components of this medication (listed in section 6).
  • If you have tuberculosis, syphilis, or viral infections, such as chickenpox or herpes.
  • In areas of skin affected by inflammation that is red/pink (rosacea), ulcers, inflammation of the sebaceous glands (acne), or skin diseases with skin thinning (atrophic skin diseases).
  • In areas of skin showing a vaccination reaction, such as redness or inflammation after vaccination.
  • In specific skin inflammation around the upper lip and chin (perioral dermatitis).
  • In bacterial or fungal infections (unless they are also being treated with specific treatment).

Warnings and Precautions

Consult your doctor or pharmacist before starting to use Lexxema emulsion.

Be particularly careful if your doctor diagnoses a skin infection caused by bacteria or fungi; then, you should also use the additional prescribed treatment for the infection, as the infection may worsen if not treated.

Anti-inflammatory medications (corticosteroids), such as the active ingredient (MPA) of Lexxema emulsion, have significant effects on the body. It is not recommended to use Lexxema emulsion on large areas of skin or for extended periods, as this significantly increases the risk of side effects.

To reduce the risk of side effects:

  • Use the lowest possible dose.
  • Use it only for the time absolutely necessary to relieve the skin condition.
  • Lexxema emulsion should not come into contact with the eyes, mouth, deep open wounds, or mucous membranes (such as the anal or genital area).
  • Lexxema emulsion should not be used on large areas of skin (more than 40% of the body surface).
  • Lexxema emulsion should not be used under airtight and waterproof materials, including bandages, dressings, clothing, or diapers, unless prescribed by your doctor.

If you use Lexxema emulsion for conditions other than those for which it has been prescribed, it may mask symptoms and make diagnosis and correct treatment more difficult.

Contact your doctor if you experience blurred vision or other visual disturbances.

If Lexxema emulsion is applied to the anal or genital area, some of its components may cause deterioration of latex products, such as condoms or diaphragms. Therefore, these products may no longer be effective as contraceptives or protectors against sexually transmitted diseases, such as HIV infection. Contact your doctor or pharmacist if you need more information.

Children

  • Use Lexxema emulsion as little as possible to reduce the risk of side effects.
  • Lexxema emulsion should not be used under airtight and waterproof materials, such as diapers, unless prescribed by your doctor.
  • Lexxema emulsion can be used in children between 4 months and 3 years if prescribed by your doctor. It is not recommended for use in children under 4 months of age.

Using Lexxema Emulsion with Other Medications

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medications, including those purchased without a prescription.

No interactions between Lexxema emulsion and other medications are known at present.

Pregnancy, Breastfeeding, and Fertility

To avoid any risk to the child, do not use Lexxema emulsion if you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, unless your doctor advises you to do so.

If your doctor recommends using Lexxema emulsion during breastfeeding, do not apply the medication to the breasts; do not let the child come into contact with treated areas.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and Using Machines

Lexxema emulsion does not affect your ability to drive or operate machinery.

Lexxema Emulsion Contains Benzyl Alcohol

This medication contains 1.25 g of benzyl alcohol per 100 g.

Benzyl alcohol may cause allergic reactions.

Benzyl alcohol may cause moderate local irritation.

3. How to Use Lexxema Emulsion

Follow your doctor's or pharmacist's instructions for using this medication exactly. If you are unsure, consult your doctor or pharmacist again.

Unless your doctor tells you otherwise, the recommended dose is:

  • Apply Lexxema emulsion in a thin layer, once a day, to the affected area, rubbing gently.
  • Generally, the treatment duration with Lexxema emulsion should not exceed two weeks. Always make the treatment as short as possible.
  • If you use Lexxema emulsion for a skin rash with inflammation and scaling on the face (seborrheic eczema), do not treat for more than one week.
  • If your skin becomes too dry, consult your doctor. You may need to apply a regulating fatty ointment in addition.

Use in Children

Lexxema emulsion can be used in children between 4 months and 3 years if prescribed by your doctor. No dose adjustments are required.

The use of Lexxema emulsion is not recommended in children under 4 months of age due to the lack of safety data.

If You Use More Lexxema Emulsion Than You Should

No risk is expected after a single overdose of Lexxema emulsion (too much, too large an area, or too frequent use). Repeated overdoses may produce side effects (see section 4, Possible Side Effects).

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicology Information Service, phone 91 562 04 20 (indicating the medication and the amount ingested).

If You Forget to Use Lexxema Emulsion

Do not use a double dose to make up for forgotten doses; if you have forgotten a dose, continue with your usual schedule as instructed by your doctor or as described in the package leaflet.

If You Stop Using Lexxema Emulsion

If you stop using Lexxema emulsion prematurely, the original symptoms of your skin problem may recur. Please contact your doctor before stopping treatment with Lexxema emulsion.

If you have any other questions about using this medication, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medications, Lexxema emulsion can cause side effects, although not everyone gets them.

The assessment of side effects is based on the following frequencies:

Very common: may affect more than 1 in 10 patients

Common: may affect up to 1 in 10 patients

Uncommon: may affect up to 1 in 100 patients

Rare: may affect up to 1 in 1,000 patients

Very rare: may affect up to 1 in 10,000 patients

Frequency not known: cannot be estimated from the available data.

  • Common:
    • Local skin irritation (such as burning sensation)
  • Uncommon:
    • Pain
    • Itching
    • Small blisters and pustules
    • Scaling
    • Superficial wounds (erosion)
    • Worsening or recurrence of eczema
    • Cracking of the skin

The use of anti-inflammatory medications, called corticosteroids (such as the active ingredient of Lexxema emulsion), on the skin may lead to the following side effects (frequency not known).

  • Thinning of the skin (atrophy)
  • Dry skin
  • Redness (erythema)
  • Appearance of red spots
  • Inflammation of the hair follicle (folliculitis)
  • Stretch marks
  • Acne
  • Specific skin inflammation around the upper lip and chin (perioral dermatitis).
  • Allergic skin reaction (contact dermatitis)
  • Changes in skin color
  • Increased hair growth
  • Side effects may occur not only in the treated area but also in completely different areas of the body. This occurs if the active ingredient (a corticosteroid) passes into the body through the skin (is absorbed). This, for example, can increase pressure in the eye (glaucoma).
  • Blurred vision.

Reporting Side Effects

If you experience any side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency's website: www.notificaram.es.

By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Lexxema Emulsion

Keep this medication out of the sight and reach of children.

Do not store above 30°C.

Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.

Validity period after first opening: 3 months.

Medications should not be disposed of via wastewater or household waste. Return the packaging and any unused medication to the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and unused medication. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Lexxema Emulsion

  • The active ingredient is methylprednisolone aceponate (MPA).
  • The other ingredients (excipients) are: medium-chain triglycerides, capric/caprylic/myristic/stearic triglyceride, macrogol-2-stearate, macrogol-21-stearate, benzyl alcohol, disodium edetate, glycerol (E-422) (85%), and purified water.

Appearance of the Product and Package Contents

Lexxema emulsion is a white cutaneous emulsion (similar to an opaque milky cream) and is available in 20 and 50 g tubes.

The tubes have a removable seal.

Not all pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

  • Italfarmaco, S.A.

C/ San Rafael, 3

28108 Alcobendas (Madrid) - Spain

Manufacturer:LEO Pharma Manufacturing Italy S.r.l.

Via E. Schering, 21

20054 Segrate (Milan) - Italy

Date of Last Revision of this Package Leaflet: August 2019

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

About the medicine

How much does LEXXEMA 1 mg/g CUTANEOUS EMULSION cost in Spain ( 2026)?

The average price of LEXXEMA 1 mg/g CUTANEOUS EMULSION in January, 2026 is around 8.71 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Alternatives to LEXXEMA 1 mg/g CUTANEOUS EMULSION in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to LEXXEMA 1 mg/g CUTANEOUS EMULSION in Poland

Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): Italfarmaco S.A.
Prescription required
Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Ointment, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Emulsion, 1 mg/g
Active substance: methylprednisolone aceponate
Manufacturer: Paul W. Beyvers GmbH
Prescription required

Alternative to LEXXEMA 1 mg/g CUTANEOUS EMULSION in Ukraine

Dosage form: cream, 15 g in a tube
Active substance: methylprednisolone aceponate
Manufacturer: PRAT "FITOFARM
Prescription not required
Dosage form: ointment, 0.1% in 15g tube
Active substance: methylprednisolone aceponate
Prescription required
Dosage form: cream, 0.1% in 5g or 15g tube
Active substance: methylprednisolone aceponate
Prescription not required

Online doctors for LEXXEMA 1 mg/g CUTANEOUS EMULSION

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LEXXEMA 1 mg/g CUTANEOUS EMULSION – subject to medical assessment and local rules.

5.0(2)
Doctor

Tomasz Grzelewski

Dermatology21 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
CameraBook a video appointment
€80
Today11:00
Today11:25
Today11:50
Today12:15
Today12:40
More times
5.0(19)
Doctor

Anna Moret

Dermatology19 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for:

  • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis.
  • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis.
  • Pediatric skin problems — from newborns to adolescents.
  • Sexually transmitted infections (STIs) and dermatovenereology.
  • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments.
  • Skin allergies and hypersensitivity reactions.
  • Mole checks, lesion evaluation, and skin cancer screening.
  • Skincare advice and personalised cosmeceutical routines.

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
€55
January 608:15
January 709:00
January 709:30
January 909:00
January 909:30
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2026 Oladoctor. All rights reserved.
VisaMastercardStripe